[1]
H. M. . Tawel, Y. M. A. . Hasen, and A. . Miles, Trans., “Cancer Testis Antigen (CTA) T21, as a Potential Diagnostic, Prognostic, and Immune-Therapeutic Targets for Malignant Tumours”., J Med Sci (Sebha), vol. 17, no. 1, pp. 1–7, Jan. 2022, doi: 10.51984/joms.v17i1.1892.